Knights of Columbus Asset Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.7M | Buy |
55,259
+8,487
| +18% | +$1.67M | 0.59% | 42 |
|
|
2026
Q1 | $9.17M | Buy |
46,772
+693
| +2% | +$135K | 0.52% | 47 |
|
|
2025
Q4 | $8M | Buy |
46,079
+1,110
| +2% | +$202K | 0.45% | 58 |
|
|
2025
Q3 | $8.57M | Sell |
44,969
-3,951
| -8% | -$701K | 0.49% | 56 |
|
|
2025
Q2 | $8.79M | Buy |
48,920
+2,526
| +5% | +$439K | 0.53% | 54 |
|
|
2025
Q1 | $7.85M | Buy |
46,394
+1,945
| +4% | +$320K | 0.54% | 55 |
|
|
2024
Q4 | $6.71M | Buy |
44,449
+2,697
| +6% | +$419K | 0.44% | 66 |
|
|
2024
Q3 | $6.48M | Sell |
41,752
-3,321
| -7% | -$496K | 0.43% | 74 |
|
|
2024
Q2 | $6.17M | Buy |
45,073
+496
| +1% | +$67.9K | 0.4% | 72 |
|
|
2024
Q1 | $5.93M | Sell |
44,577
-2,222
| -5% | -$288K | 0.43% | 63 |
|
|
2023
Q4 | $6.45M | Buy |
46,799
+1,038
| +2% | +$136K | 0.42% | 68 |
|
|
2023
Q3 | $5.58M | Buy |
45,761
+647
| +1% | +$86.2K | 0.51% | 50 |
|
|
2023
Q2 | $6.34M | Sell |
45,114
-380
| -0.8% | -$52.4K | 0.57% | 34 |
|
|
2023
Q1 | $6.44M | Hold |
45,494
| – | – | 0.63% | 23 |
|
|
2022
Q4 | $7.12M | Sell |
45,494
-3,890
| -8% | -$559K | 0.74% | 22 |
|
|
2022
Q3 | $6.06M | Sell |
49,384
-2,664
| -5% | -$351K | 0.62% | 32 |
|
|
2022
Q2 | $6.92M | Buy |
52,048
+473
| +0.9% | +$64.5K | 0.69% | 31 |
|
|
2022
Q1 | $7.06M | Buy |
51,575
+1,091
| +2% | +$152K | 0.6% | 43 |
|
|
2021
Q4 | $8.73M | Buy |
50,484
+2,003
| +4% | +$305K | 0.71% | 24 |
|
|
2021
Q3 | $7.04M | Buy |
48,481
+442
| +0.9% | +$64.7K | 0.63% | 33 |
|
|
2021
Q2 | $6.34M | Buy |
48,039
+892
| +2% | +$117K | 0.58% | 48 |
|
|
2021
Q1 | $6.05M | Buy |
47,147
+2,266
| +5% | +$279K | 0.59% | 38 |
|
|
2020
Q4 | $5.35M | Sell |
44,881
-3,149
| -7% | -$384K | 0.57% | 36 |
|
|
2020
Q3 | $5.5M | Buy |
48,030
+3,075
| +7% | +$363K | 0.68% | 32 |
|
|
2020
Q2 | $5.12M | Buy |
44,955
+4
| +0% | +$424 | 0.63% | 33 |
|
|
2020
Q1 | $3.61M | Buy |
44,951
+6,843
| +18% | +$708K | 0.46% | 61 |
|
|
2019
Q4 | $4.07M | Buy |
+38,108
| New | +$3.97M | 0.36% | 70 |
|
|
2018
Q2 | – | Sell |
-6,900
| Closed | -$719K | – | 90 |
|
|
2018
Q1 | $692K | Buy |
6,900
+1,900
| +38% | +$195K | 0.32% | 78 |
|
|
2017
Q4 | $492K | Hold |
5,000
| – | – | 0.32% | 80 |
|
|
2017
Q3 | $468K | Sell |
5,000
-100
| -2% | -$10.6K | 0.32% | 83 |
|
|
2017
Q2 | $567K | Sell |
5,100
-2,200
| -30% | -$233K | 0.39% | 81 |
|
|
2017
Q1 | $717K | Buy |
+7,300
| New | +$696K | 0.51% | 77 |
|
Other funds holding DGX
MGP
AIM
Knights of Columbus Asset Advisors's DGX Position: Q2 2026 in Review
Knights of Columbus Asset Advisors increased its Quest Diagnostics (DGX) stake by 18% in Q2 2026, buying an estimated $1.67M and bringing the position to 55,259 shares worth $11.7M. The position accounts for 0.59% of the portfolio, ranked #42.
Knights of Columbus Asset Advisors first reported a position in DGX in Q1 2017 and has held it in 32 quarters since. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Knights of Columbus Asset Advisors held 55,259 shares of Quest Diagnostics worth $11.7M as of Q2 2026.
- Knights of Columbus Asset Advisors bought 8,487 Quest Diagnostics shares in Q2 2026, an estimated $1.67M.
- Quest Diagnostics made up 0.59% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #42 holding.
- Knights of Columbus Asset Advisors first reported a position in Quest Diagnostics in Q1 2017 and has held it in 32 quarters since.
- 629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.